MORGAN STANLEY PLC/CALL/CALERES/64/0.1/20.09.24 Share Price

Warrant

DE000ME9P4C3

Real-time Bid/Ask 16:12:25 23/05/2024 BST
0.037 EUR / 0.068 EUR +39.47% Intraday chart for MORGAN STANLEY PLC/CALL/CALERES/64/0.1/20.09.24
Current month-33.33%
1 month-26.92%
Date Price Change
23/05/24 0.037 -2.63%
22/05/24 0.038 -19.15%
21/05/24 0.047 -2.08%
20/05/24 0.048 -2.04%
17/05/24 0.049 -36.36%

Delayed Quote Börse Stuttgart

Last update May 23, 2024 at 03:01 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying CALERES, INC.
Issuer Morgan Stanley
WKN ME9P4C
ISINDE000ME9P4C3
Date issued 06/03/2024
Strike 64 $
Maturity 20/09/2024 (120 Days)
Parity 10 : 1
Emission price 0.12
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.13
Lowest since issue 0.037
Spread 0.031
Spread %45.59%

Company Profile

Caleres, Inc. is a global footwear company. The Company operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures and distributes footwear for people of all ages. The Company operates through two segments: Famous Footwear and Brand Portfolio. The Famous Footwear segment consists of its Famous Footwear retail stores, famousfootwear.com and famousfootwear.ca. The Famous Footwear segment operates over 860 stores selling primarily branded footwear for the entire family. The Brand Portfolio segment includes its wholesale operations that designs, develops, sources, manufactures, markets and distributes branded, licensed and private-label footwear primarily to online retailers, national chains, department stores, independent retailers and mass merchandisers, as well as Company-owned Famous Footwear, Sam Edelman, Naturalizer and Allen Edmonds stores and e-commerce businesses, including naturalizer.com, naturalizer.ca, naturalizer.co.uk and others.
Sector
-
More about the company

Ratings for Caleres, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Caleres, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
36.01 USD
Average target price
44 USD
Spread / Average Target
+22.19%
Consensus